12/19/2024
3:14 PM | Adverum Biotechnologies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/17/2024
4:11 PM | Adverum Biotechnologies (Subject)
Rush Ryan Bradford (Filed by)
| Form SCHEDULE 13G | |
11/14/2024
5:40 PM | Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G/A | |
11/14/2024
5:57 PM | Adverum Biotechnologies (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
4:49 PM | Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
11/04/2024
3:42 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:44 PM | Adverum Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
10/31/2024
11:41 AM | Adverum Biotechnologies (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G | |
10/30/2024
8:34 PM | Adverum Biotechnologies (Subject)
Stern Augustus (Filed by)
| Form SC 13G | |
10/23/2024
12:34 PM | Adverum Biotechnologies (Subject)
Principia Wealth Advisory, LLC (Filed by)
| Form SC 13G | |
10/22/2024
5:06 PM | Adverum Biotechnologies (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/12/2024
3:08 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:10 PM | Adverum Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/22/2024
3:24 PM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2024
3:38 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:47 PM | Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:48 PM | Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:48 PM | Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:49 PM | Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:50 PM | Adverum Biotechnologies (Issuer)
Ozden Rabia Gurses (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:42 PM | Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2024
3:43 PM | Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:43 PM | Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:44 PM | Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:45 PM | Adverum Biotechnologies (Issuer)
Whitcup Scott M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:46 PM | Adverum Biotechnologies (Issuer)
Tuckson Reed Vaughn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:10 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2024
11:15 PM | Adverum Biotechnologies (Filer)
| Form EFFECT | |
03/26/2024
11:15 PM | Adverum Biotechnologies (Filer)
| Form EFFECT | |
03/21/2024
4:24 PM | Adverum Biotechnologies (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/20/2024
4:04 PM | Adverum Biotechnologies (Filer)
| Form 424B3 | |
03/20/2024
3:13 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
6:05 PM | Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:06 PM | Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:07 PM | Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:40 PM | Adverum Biotechnologies (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/22/2024
2:47 PM | Adverum Biotechnologies (Subject)
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Logos Global Management LP (Filed by)
| Form SC 13G | |
02/21/2024
2:39 PM | Adverum Biotechnologies (Filer)
| Form D
Notice of Exempt Offering of Securities | |
Cackling Kamala hates this company (Ad) Do you want to see one of the most exciting election trades of all time?
A trade that could help America become 100% energy independent…
Reduce energy costs to virtually zero…
And hand investors what could be a stunning return in just a few years’ time?
It all has to do with a little known company that is helping to kick off the next great American energy revolution.  Before that happens, you need to see the details here. |
02/15/2024
3:17 PM | Adverum Biotechnologies (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
02/14/2024
7:26 PM | Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024
6:34 PM | Adverum Biotechnologies (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
| Form SC 13G/A | |
02/12/2024
9:13 AM | Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
02/09/2024
4:50 PM | Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:51 PM | Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:35 AM | Adverum Biotechnologies (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
7:45 AM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
10:36 AM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/06/2024
3:47 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free ADVM Stock Alerts